Questioning the clinical significance of upper gastrointestinal cytomegalovirus disease following heart transplantation

Stephen O. Slusser, John Boehmer, John Zurlo, Francesca Ruggiero, Ann Ouyang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We performed a retrospective review of patients who underwent esophagogastroduodenoscopy after heart transplantation to determine the clinical setting in which upper gastrointestinal cytomegalovirus disease is identified. No gastrointestinal cytomegalovirus disease was found prior to transplant 51 and this period (from transplant 1 to 50) corresponded to a time when significantly fewer esophagogastroduodenoscopies included biopsy. Patients in whom cytomegalovirus was identified were more likely to have been CMV seronegative and to have received a heart from a seropositive donor (60% vs 20%, P=0.029). In addition, patients with cytomegalovirus used aspirin more commonly (90% vs 31%, P=0.001), and underwent esophagogastroduodenoscopy earlier after transplantation (123d vs 652d, P=0.029). We conclude that factors that increase the use of esophagogastroduodenoscopy and biopsy in the early transplant period increase the likelihood of identifying cytomegalovirus in gastrointestinal tissue. However, the clinical course and significance of cytomegalovirus identified in the upper gastrointestinal tract in heart transplant patients may be difficult to discern.

Original languageEnglish (US)
Pages (from-to)1824-1830
Number of pages7
JournalDigestive Diseases and Sciences
Volume40
Issue number8
DOIs
StatePublished - Aug 1 1995

Fingerprint

Gastrointestinal Diseases
Heart Transplantation
Cytomegalovirus
Digestive System Endoscopy
Transplants
Biopsy
Upper Gastrointestinal Tract
Aspirin
Transplantation
Tissue Donors

All Science Journal Classification (ASJC) codes

  • Physiology
  • Gastroenterology

Cite this

@article{4e99377290f74e5a95536b0e8f0c6487,
title = "Questioning the clinical significance of upper gastrointestinal cytomegalovirus disease following heart transplantation",
abstract = "We performed a retrospective review of patients who underwent esophagogastroduodenoscopy after heart transplantation to determine the clinical setting in which upper gastrointestinal cytomegalovirus disease is identified. No gastrointestinal cytomegalovirus disease was found prior to transplant 51 and this period (from transplant 1 to 50) corresponded to a time when significantly fewer esophagogastroduodenoscopies included biopsy. Patients in whom cytomegalovirus was identified were more likely to have been CMV seronegative and to have received a heart from a seropositive donor (60{\%} vs 20{\%}, P=0.029). In addition, patients with cytomegalovirus used aspirin more commonly (90{\%} vs 31{\%}, P=0.001), and underwent esophagogastroduodenoscopy earlier after transplantation (123d vs 652d, P=0.029). We conclude that factors that increase the use of esophagogastroduodenoscopy and biopsy in the early transplant period increase the likelihood of identifying cytomegalovirus in gastrointestinal tissue. However, the clinical course and significance of cytomegalovirus identified in the upper gastrointestinal tract in heart transplant patients may be difficult to discern.",
author = "Slusser, {Stephen O.} and John Boehmer and John Zurlo and Francesca Ruggiero and Ann Ouyang",
year = "1995",
month = "8",
day = "1",
doi = "10.1007/BF02212708",
language = "English (US)",
volume = "40",
pages = "1824--1830",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Kluwer Academic Publishers-Plenum Publishers",
number = "8",

}

Questioning the clinical significance of upper gastrointestinal cytomegalovirus disease following heart transplantation. / Slusser, Stephen O.; Boehmer, John; Zurlo, John; Ruggiero, Francesca; Ouyang, Ann.

In: Digestive Diseases and Sciences, Vol. 40, No. 8, 01.08.1995, p. 1824-1830.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Questioning the clinical significance of upper gastrointestinal cytomegalovirus disease following heart transplantation

AU - Slusser, Stephen O.

AU - Boehmer, John

AU - Zurlo, John

AU - Ruggiero, Francesca

AU - Ouyang, Ann

PY - 1995/8/1

Y1 - 1995/8/1

N2 - We performed a retrospective review of patients who underwent esophagogastroduodenoscopy after heart transplantation to determine the clinical setting in which upper gastrointestinal cytomegalovirus disease is identified. No gastrointestinal cytomegalovirus disease was found prior to transplant 51 and this period (from transplant 1 to 50) corresponded to a time when significantly fewer esophagogastroduodenoscopies included biopsy. Patients in whom cytomegalovirus was identified were more likely to have been CMV seronegative and to have received a heart from a seropositive donor (60% vs 20%, P=0.029). In addition, patients with cytomegalovirus used aspirin more commonly (90% vs 31%, P=0.001), and underwent esophagogastroduodenoscopy earlier after transplantation (123d vs 652d, P=0.029). We conclude that factors that increase the use of esophagogastroduodenoscopy and biopsy in the early transplant period increase the likelihood of identifying cytomegalovirus in gastrointestinal tissue. However, the clinical course and significance of cytomegalovirus identified in the upper gastrointestinal tract in heart transplant patients may be difficult to discern.

AB - We performed a retrospective review of patients who underwent esophagogastroduodenoscopy after heart transplantation to determine the clinical setting in which upper gastrointestinal cytomegalovirus disease is identified. No gastrointestinal cytomegalovirus disease was found prior to transplant 51 and this period (from transplant 1 to 50) corresponded to a time when significantly fewer esophagogastroduodenoscopies included biopsy. Patients in whom cytomegalovirus was identified were more likely to have been CMV seronegative and to have received a heart from a seropositive donor (60% vs 20%, P=0.029). In addition, patients with cytomegalovirus used aspirin more commonly (90% vs 31%, P=0.001), and underwent esophagogastroduodenoscopy earlier after transplantation (123d vs 652d, P=0.029). We conclude that factors that increase the use of esophagogastroduodenoscopy and biopsy in the early transplant period increase the likelihood of identifying cytomegalovirus in gastrointestinal tissue. However, the clinical course and significance of cytomegalovirus identified in the upper gastrointestinal tract in heart transplant patients may be difficult to discern.

UR - http://www.scopus.com/inward/record.url?scp=0029122911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029122911&partnerID=8YFLogxK

U2 - 10.1007/BF02212708

DO - 10.1007/BF02212708

M3 - Article

C2 - 7648986

AN - SCOPUS:0029122911

VL - 40

SP - 1824

EP - 1830

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 8

ER -